Menu
Back to User profile » Dr Abayomi Ogundele
Papers published by Dr Abayomi Ogundele:
Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca
Sheppard J, Bergmann M, Schechter BA, Luchs J, Ogundele A, Karpecki P
Clinical Ophthalmology 2021, 15:129-140
Published Date: 12 January 2021
The Prevalence and Incidence of Dry Eye Disease Among Patients Using Continuous Positive Airway Pressure or Other Nasal Mask Therapy Devices to Treat Sleep Apnea
Matossian C, Song X, Chopra I, Sainski-Nguyen A, Ogundele A
Clinical Ophthalmology 2020, 14:3371-3379
Published Date: 15 October 2020
Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease
Burade V, Zalawadia R, Patel A, Ogundele A
Clinical Ophthalmology 2020, 14:2747-2755
Published Date: 21 September 2020
Physician Satisfaction with Anti-Inflammatory Topical Medications for the Treatment of Dry Eye Disease
White DE, Zhao Y, Jayapalan H, Machiraju P, Periyasamy R, Ogundele A
Clinical Ophthalmology 2020, 14:931-938
Published Date: 25 March 2020
Treatment Satisfaction Among Patients Using Anti-Inflammatory Topical Medications for Dry Eye Disease
White DE, Zhao Y, Jayapalan H, Machiraju P, Periyasamy R, Ogundele A
Clinical Ophthalmology 2020, 14:875-883
Published Date: 19 March 2020
Real-World Treatment Patterns Of Cyclosporine Ophthalmic Emulsion And Lifitegrast Ophthalmic Solution Among Patients With Dry Eye
White DE, Zhao Y, Ogundele A, Fulcher N, Acs A, Moore-Schiltz L, Karpecki PM
Clinical Ophthalmology 2019, 13:2285-2292
Published Date: 22 November 2019
A phase 1, open-label, single-arm study evaluating the ocular safety of OTX-101 and systemic absorption of cyclosporine in healthy human volunteers
Karpecki PM, Weiss SL, Kramer WG, O'Connor P, Evans D, Johnston J, Jasper AL, Justice A, Ogundele AB, Devries D
Clinical Ophthalmology 2019, 13:591-596
Published Date: 5 April 2019